R&D 4 years on: Remembering the COVID-19 pandemic This year, Monday 11th March marked four years since the World Health Organization (WHO) declared COVID-19 a global pandemic.
Patients Protecting the immunocompromised: Preventative measures agai... COVID-19 vaccines are not as effective in immunocompromised individuals as they are in the general population, due to an inability to produce a robust protective response to the vaccine.
News Merck rare tumour drug Ezmekly backed for NHS use Merck's drug for tumours associated with rare disease neurofibromatosis type 1, Ezmekly, has been cleared for NHS use in children as young as two.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
